Industry Updates

Vivantis brings its PCR kits to Biotechnica


Vivantis Technologies, who specialise in the production of restriction enzymes, DNA extraction kits, DNA amplification reagents and other related products for molecular biology research are exhibiting at the up-coming Biotechnica in Hannover from 6th – 8th October.

Vivantis will showcase the extensive range of quality products including its latest PCR kits. Real time PCR has become one of the gold standard approaches in gene quantification for the detection of infectious diseases owing to its sensitivity, specificity, speed and quantitative features. ViPrimePLUS PCR/RT-qPCR products from Vivantis offer rapid and reliable qPCR solutions with more than 200 kits for detection and quantification of pathogens in human and veterinary applications as well as meat identification. The primer and probes are specifically designed to have 100% specificity against a broad range of reference samples.

The ViPrimePLUS PCR/RT-qPCR products are equipped with Taqman probe technology, are fast and easy to use, have a high sensitivity and have high specific genome detection capability.

On the stand (C10/1) in Hall 9 will be a range of products and information from Vivantis as well as its sister companies Stemmera [stem cell products] and Hercuvan [ thermal cyclers, microcentrifuges and pipettors]. Staff from Malaysia and Europe will be on hand to discuss product selection. Opportunities also exist to become a distributor for Vivantis and other brands so prospective distributors as also welcome to visit the stand.

Says Vivantis: “ we are looking forward to meeting both current and potential new customers for our products and we are very excited about our expansion plans within Europe. Exhibiting at Biotechnica shows our ongoing commitment to this region”.

Latest Euroscicon Tweets

Error: You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: